YC W16 · Acquired

Luminist Labs

Diagnostic platform for early detection of liver disease

Class: Winter 2016
Status: Acquired
Industry: Healthcare
Location: New York City, NY, USA
Team size: 2

Website

http://luministlabs.com

About

Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.